Search Results

FILTER BY

1 - 5 of 5 matches

Sort by:
  • PresentationTCT 2024

    TCT 235: Efficacy and Safety of Bivalirudin and Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients Who Underwent Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis

    Presenter:  

    Hamza Naveed

    October 28, 2024

  • PresentationTCT 2018

    TCT-111: Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of a Potent P2Y12 Inhibitor in STEMI: A Pre-Specified Sub-Analysis of the ATLANTIC Trial

    Presenter:  

    Anne Tavenier, George D. Dangas, Germano Di Sciascio

    September 21, 2018

  • PresentationTCT 2013

    Featured Trial of the Day: EUROMAX: A Prospective, Randomized Trial of Ambulance Initiation of Bivalirudin vs. Heparin ± Glycoprotein IIb/IIIa Inhibitors in Patients with STEMI...

    Presenter:  

    Philippe Gabriel Steg

    October 30, 2013

  • PresentationTCT 2012

    Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

    Presenter:  

    Gilles Montalescot

    October 25, 2012

  • PresentationTCT 2012

    Glycoprotein IIb/IIIa Inhibitors in the Era of Bivalirudin and New Oral Antiplatelet Agents: Is Intracoronary Application the Standard of Choice?

    Presenter:  

    Rajesh Dave

    October 25, 2012